These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 9813253)

  • 1. Designed beta-sheet-forming peptide 33mers with potent human bactericidal/permeability increasing protein-like bactericidal and endotoxin neutralizing activities.
    Mayo KH; Haseman J; Ilyina E; Gray B
    Biochim Biophys Acta; 1998 Sep; 1425(1):81-92. PubMed ID: 9813253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing structure-activity relationships in bactericidal peptide betapep-25.
    Dings RP; Haseman JR; Mayo KH
    Biochem J; 2008 Aug; 414(1):143-50. PubMed ID: 18489259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B/PI-derived synthetic peptides: synergistic effects in tethered bactericidal and endotoxin neutralizing peptides.
    Gray BH; Haseman JR; Mayo KH
    Biochim Biophys Acta; 1995 May; 1244(1):185-90. PubMed ID: 7766657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topomimetics of amphipathic beta-sheet and helix-forming bactericidal peptides neutralize lipopolysaccharide endotoxins.
    Chen X; Dings RP; Nesmelova I; Debbert S; Haseman JR; Maxwell J; Hoye TR; Mayo KH
    J Med Chem; 2006 Dec; 49(26):7754-65. PubMed ID: 17181157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function relationships in novel peptide dodecamerswith broad-spectrum bactericidal and endotoxin-neutralizing activities.
    Mayo KH; Haseman J; Young HC; Mayo JW
    Biochem J; 2000 Aug; 349 Pt 3(Pt 3):717-28. PubMed ID: 10903132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal activity of synthetic peptides based on the structure of the 55-kilodalton bactericidal protein from human neutrophils.
    Gray BH; Haseman JR
    Infect Immun; 1994 Jul; 62(7):2732-9. PubMed ID: 8005662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure/function studies of an endotoxin-neutralizing peptide derived from bactericidal/permeability-increasing protein.
    Wasiluk KR; Leslie DB; Vietzen PS; Mayo KH; Dunn DL
    Surgery; 2004 Aug; 136(2):253-60. PubMed ID: 15300188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A folding pathway for betapep-4 peptide 33mer: from unfolded monomers and beta-sheet sandwich dimers to well-structured tetramers.
    Mayo KH; Ilyina E
    Protein Sci; 1998 Feb; 7(2):358-68. PubMed ID: 9521112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designed beta-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells.
    Mayo KH; van der Schaft DW; Griffioen AW
    Angiogenesis; 2001; 4(1):45-51. PubMed ID: 11824378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a potent novel endotoxin antagonist.
    Uknis ME; Wasiluk KR; Acton RD; Klaerner HG; Dahlberg PS; Ilyina EE; Haseman JR; Gray BH; Mayo KH; Dunn DL
    Surgery; 1997 Aug; 122(2):380-5. PubMed ID: 9288144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure, activity and interactions of the cysteine deleted analog of tachyplesin-1 with lipopolysaccharide micelle: Mechanistic insights into outer-membrane permeabilization and endotoxin neutralization.
    Saravanan R; Mohanram H; Joshi M; Domadia PN; Torres J; Ruedl C; Bhattacharjya S
    Biochim Biophys Acta; 2012 Jul; 1818(7):1613-24. PubMed ID: 22464970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains.
    Lockwood NA; Haseman JR; Tirrell MV; Mayo KH
    Biochem J; 2004 Feb; 378(Pt 1):93-103. PubMed ID: 14609430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities.
    Hirata M; Shimomura Y; Yoshida M; Wright SC; Larrick JW
    Prog Clin Biol Res; 1994; 388():147-59. PubMed ID: 7831355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing potent antimicrobial peptides by disulphide linked dimerization and N-terminal lipidation to increase antimicrobial activity and membrane perturbation: Structural insights into lipopolysaccharide binding.
    Datta A; Kundu P; Bhunia A
    J Colloid Interface Sci; 2016 Jan; 461():335-345. PubMed ID: 26407061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
    Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
    Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
    Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs.
    Kondejewski LH; Farmer SW; Wishart DS; Kay CM; Hancock RE; Hodges RS
    J Biol Chem; 1996 Oct; 271(41):25261-8. PubMed ID: 8810288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.